Denosumab and zoledronic acid therapy improves BMD in periprosthetic bone

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-06-20 04:00 GMT | Update On 2023-06-20 07:03 GMT

A new study by Xiao Li and team showed that denosumab and zoledronic acid (ZA) are effective treatments against decline in periprosthetic bone mineral density. The findings of this study were published in Archives of Osteoporosis.

Following a total hip arthroplasty (THA), periprosthetic bone mineral density (BMD) loss may endanger the longevity of implants. By suppressing osteoclast activity, zoledronic acid and denosumab were successful in lowering bone loss in diseases linked to rapid bone turnover. In order to evaluate the effectiveness and safety of ZA and denosumab for periprosthetic BMD loss following THA, a meta-analysis was conducted.

MEDLINE, Embase, PubMed, the Cochrane Central Register of Controlled Trials, and the Web of Science were all thoroughly searched from 1980 to 2022 for randomized controlled trials (RCTs) including ZA or denosumab with THA. The Cochrane Review Manager 5 (RevMan) version 5.41 carried out the meta-analysis. For methodological quality and overall evidence quality, the Cochrane Risk of Bias Tool and GRADEpro were used, respectively.

The key findings of this study were:

1. Finally, 480 individuals from nine RCTs were enrolled and examined.

2. The patients in the intervention group experienced significantly less periprosthetic BMD loss in Gruen zone 7 at 3 months (MD = 4.30, 95% CI: 1.78-6.82, P = 0.0008), 6 months (MD = 7.71, 95% CI: 5.41-10.02, P 0.00001), and 12 months (MD = 8.19, 95% CI: 5.97-10.42,P < 0.00001) after THA than the patients in the control group.

3. There were no reported severe adverse events (AEs).

The authors advocate ZA or denosumab therapy for periprosthetic bone mineral density loss in the present study based on evidence on the effectiveness and safety of ZA and denosumab.

Reference:

Li, X., Han, J., Shi, X., Bi, Z., & Liu, J. (2023). Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. In Archives of Osteoporosis (Vol. 18, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1007/s11657-023-01227-9

Article Source : Archives of Osteoporosis

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Jacinthlyn Sylvia

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Imposter Syndrome among Orthopaedic Surgery residents extremely common and disproportionately affects female residents: Study

2025-08-15 14:45 GMT

Denosumab and zoledronic acid therapy improves BMD in periprosthetic bone

Similar News

Imposter Syndrome among Orthopaedic Surgery residents extremely common and disproportionately affects female residents: Study

Alcohol Consumption Greatly Increases Risk of Hyperuricemia and Gout, Especially among Males: Study

RECK effective opioid-sparing local anesthetic for patients undergoing posterior spinal fusion: study

Stopping HRT leads to a period of higher risk of bone fracture for most women: Study

18F-FDG PET/CT effective in diagnosing refractory fracture-related infections, suggests study

DMARD Use and Rheumatoid Arthritis Raise Mortality in Bronchiectasis Patients: Study Shows

Personalized Therapy May Offer Lasting Relief for Chronic Back Pain: Study Finds

Vitiligo Causally Linked to Rheumatoid Arthritis, Type 1 Diabetes, and Alopecia Areata: Study